Putting Big Bad Pharma Back On Trial In The COVID-19 Era

Putting Big Bad Pharma Back On Trial In The COVID-19 Era

After graduating from Columbia University with a chemical engineering degree, my grandfather went on to work for Pfizer for almost two decades, culminating his career as the company’s Global Director of New Products. I was rather proud of this fact growing up — it felt as if this father figure, who raised me for several years during my childhood, had somehow played a role in saving lives.

Invasion Of The Fact Checkers

In the past five years, a cadre of fact-checkers has marched through the institutions of journalism and installed itself in the U.S. media as a privatized, quasi-governmental regulatory agency. What’s wrong with facts, you say? Fueled by a panic over misinformation, the fact-checking industry is shifting the media’s primary obligation away from pursuing the truth and toward upholding vague notions of public safety, which it gets to define. In the course of this transformation, journalists are being turned into rent-a-cops whose job is to enforce an official consensus that is treated as a civic good by those who benefit from—and pay for—its protection.

How The CIA Spied On President Donald Trump

On Friday, Special Counsel John Durham filed a motion relating to a defense firm’s potential conflict of interest in the Michael Sussmann case. The conflict itself is certainly intriguing, with Sussmann’s lawyers at Latham & Watkins LLP (Latham) having represented potential witnesses in the case, including Perkins Coie, former Perkins Coie (and Clinton Campaign general counsel) Marc Elias, the Hillary Clinton Campaign, and Hillary for America.